Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 7/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27685014 | 0.94 | ACHE (0.45) | CA12CA1CA9NAAAACHE | |
| SCHEMBL9432487 | 0.93 | NAAA (0.49) | NAAAACHEDNM1EPHX1CNR1 | |
| SCHEMBL27684966 | 0.91 | ACHE (0.44) | CA12CA1CA9NAAAACHE | |
| SCHEMBL2197495 | 0.90 | CA12 (0.45) | CA12CA1CA9NAAAACHE | |
| SCHEMBL6835933 | 0.90 | EPHX1 (0.48) | CA12CA1CA9ACHEDNM1 | |
| SCHEMBL25227149 | 0.88 | EPHX1 (0.54) | CA12CA1CA9NAAADNM1 | |
| SCHEMBL424525 | 0.88 | EPHX1 (0.54) | CA12CA1CA9NAAADNM1 | |
| SCHEMBL8763583 | 0.87 | CA12 (0.42) | CA12CA1CA9NAAAACHE | |
| SCHEMBL6235608 | 0.86 | ACHE (0.47) | NAAAACHEDNM1MMP2EPHX1 | |
| SCHEMBL25276689 | 0.86 | EPHX1 (0.57) | CA12CA1CA9NAAADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9150673-B2 | Process for preparing (meth)acrylic esters | BASF SE (DE) | 2015-10-06 | — | — | US | disclosed |
| US-20130178592-A1 | PROCESS FOR PREPARING (METH)ACRYLIC ESTERS | BASF SE (DE) | 2013-07-11 | — | — | US | disclosed |
| US-8263371-B2 | Catalyzed preparation of (meth)acrylates of N-hydroxyalkylated amides | BASF AKTIENGESELLSCHAFT (DE) | 2012-09-11 | — | — | US | disclosed |
| US-7993886-B2 | Catalyzed preparation of (meth)acrylates of N-hydroxyalkylated amides | BASF AKTIENGESELLSHAFT (DE) | 2011-08-09 | — | — | US | disclosed |
| US-20110171697-A1 | CATALYZED PREPARATION OF (METH)ACRYLATES OF N-HYDROXYALKYLATED AMIDES | BASF AKTIENGESELLSHAFT (DE) | 2011-07-14 | — | — | US | disclosed |
| US-20100285542-A1 | CATALYZED PREPARATION OF (METH)ACRYLATES OF N-HYDROXYALKYLATED AMIDES | BASF AKTIENGESELLSHAFT (DE) | 2010-11-11 | — | — | US | disclosed |
| US-7816485-B2 | Catalyzed preparation of (meth)acrylates of N-hydroxyalkylated amides | BASF AKTIENGESELLSCHAFT (DE) | 2010-10-19 | — | — | US | disclosed |
| US-20060036063-A1 | Catalyzed preparation of (meth)acrylates of N-hydroxyalkylated amides | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100285542-A1 | CATALYZED PREPARATION OF (METH)ACRYLATES OF N-HYDROXYALKYLATED AMIDES | NAAA, APEH, NAA15 | CA12 1699/4885CA1 1754/4885CA9 808/4885 |
| US-20110171697-A1 | CATALYZED PREPARATION OF (METH)ACRYLATES OF N-HYDROXYALKYLATED AMIDES | NAAA, APEH, NAA15 | CA12 1699/4885CA1 1754/4885CA9 808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.